Encephalopathy in severe SARS-CoV2 infection: Inflammatory or infectious?

María José Abenza-Abildúa1, Susana Novo-Aparicio2, Raúl Moreno-Zabaleta3

  • 1Neurology Department, Infanta Sofía University Hospital, Madrid, Spain.

Insights

This case study details a patient with severe SARS-CoV-2 infection who developed inflammatory encephalopathy. Neurological symptoms resolved within 72 hours, highlighting a potential COVID-19 neurological complication.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Radiology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can present with diverse neurological manifestations.
  • Encephalopathy is a recognized, albeit less common, complication of viral infections, including COVID-19.

Observation:

  • A 56-year-old woman with severe SARS-CoV-2 infection developed acute confusional syndrome (hyperactive delirium) with neurological deficits.
  • Cranial magnetic resonance imaging (MRI) revealed bilateral, symmetrical white matter signal abnormalities and temporal lobe thickening.
  • Cerebrospinal fluid analysis was unremarkable, ruling out common infectious or inflammatory causes.

Findings:

  • The patient's presentation and MRI findings were consistent with inflammatory encephalopathy.
  • The neurological symptoms resolved spontaneously within 72 hours of onset.
  • This case suggests a direct or indirect inflammatory process affecting the brain in SARS-CoV-2 infection.

Implications:

  • Understanding the spectrum of neurological complications associated with SARS-CoV-2 is crucial for timely diagnosis and management.
  • Atypical MRI findings in encephalopathy during COVID-19 require careful consideration of inflammatory processes.
  • Further research is needed to elucidate the mechanisms of SARS-CoV-2-related encephalopathy and its long-term effects.